相似文献/References:
[1]张媛媛,梁荣仙,王敬,等.急性脑梗死患者氧化低密度脂蛋白、hs-CRP、Hcy、D-二聚体联合检测的临床意义[J].陕西医学杂志,2016,(10):1396.
[2]夏 敏,陈光斌,敖 锋.磁共振弥散张量成像诊断早期帕金森病研究进展[J].陕西医学杂志,2021,50(10):1314.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.035]
XIA Min,CHEN Guangbin,AO Feng.Advances in the application of MRI diffusion tensor imaging in diagnosis of early Parkinson's disease[J].,2021,50(10):1314.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.035]
[3]赵晓娟,权青云,孟宏涛,等.α-突触核蛋白与帕金森病伴发快速眼动期睡眠行为障碍相关性研究[J].陕西医学杂志,2022,51(2):191.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.014]
ZHAO Xiaojuan,QUAN Qingyun,MENG Hongtao,et al.Relationship between α-synuclein and rapid eye movement sleep behavior disorder in Parkinson's disease[J].,2022,51(10):191.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.014]
[4]刘 斌,杨浩辉,任 伯,等.丁苯酞联合美多芭对帕金森病伴抑郁模型小鼠黑质纹状体Ⅱ型髓系细胞触发受体及小胶质细胞炎症标志物表达的影响[J].陕西医学杂志,2022,51(12):1477.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.003]
LIU Bin,YANG Haohui,REN Bo,et al.Effects of butylphthalide combined with medoba on expression of TREM2 and microglia inflammatory markers in substantia nigra striatum of Parkinson's disease with depression model mice[J].,2022,51(10):1477.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.003]
[5]高继英,石代乐,王 刚.长链非编码RNA NORAD过表达通过靶向调控miR-132-5p/Bcl-2改善MPP+诱导的帕金森细胞模型损伤实验研究[J].陕西医学杂志,2023,52(4):363.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.001]
GAO Jiying,SHI Daile,WANG Gang.LncRNA NORAD overexpression improves MPP+ induced Parkinson cell model injury by targeting miR-132-5p/Bcl-2[J].,2023,52(10):363.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.001]
[6]朱雪莲,乔 飞,穆耶赛尔·马合木提,等.帕金森病患者血铜蓝白水平与黑质铁沉积相关性分析[J].陕西医学杂志,2024,(7):940.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.016]
ZHU Xuelian,QIAO Fei,MUYESAIR Mahemuti,et al.Correlation analysis between ceruloplasmin level and iron deposition in substantia nigra in patients with Parkinson's disease[J].,2024,(10):940.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.016]
[7]孙庆,李佳佳,许舒婷,等.AP39调控细胞外信号调节激酶1/2通路促进帕金森病动物模型神经再生的研究进展[J].陕西医学杂志,2026,(1):140.[doi:DOI:10.3969/j.issn.1000-7377.2026.01.026]
SUN Qing,LI Jiajia,XU Shuting,et al.Research progress of AP39 regulating ERK1/2 pathway to promote nerve regeneration in animal models of Parkinson’s disease[J].,2026,(10):140.[doi:DOI:10.3969/j.issn.1000-7377.2026.01.026]
[8]白杨,杨越,陈方方.Toll样受体4抗体通过抑制炎症与氧化应激改善帕金森病模型小鼠的神经损伤及运动功能障碍[J].陕西医学杂志,2026,(7):888.[doi:DOI:10.3969/j.issn.1000-7377.2026.07.004]
BAI Yang,YANG Yue,CHEN Fangfang.TLR4 antibody alleviates dopaminergic neurodegeneration and motor dysfunction in a mouse model of Parkinson’s Disease by suppressing neuroinflammation and oxidative stress[J].,2026,(10):888.[doi:DOI:10.3969/j.issn.1000-7377.2026.07.004]